CBD in Europe: The Complete Country-by-Country Guide to Regulations

CBD in Europe, a Multi-Speed Market

The European CBD market is an undeniable economic force. With projections exceeding €2 billion by 2025, it attracts entrepreneurs from across the continent. However, behind this meteoric growth lies a complex and fragmented reality: a regulatory labyrinth where each border redraws the rules of the game.

From one country to another, authorized THC levels, the legal status of flower or oils, and marketing requirements vary drastically. For a CBD entrepreneur with European ambitions, this heterogeneity is not just an administrative headache; it's a direct threat to business continuity, especially when it comes to payments.

A transaction seamlessly accepted in Germany can trigger an alert and freeze your account if it originates from a customer in Spain. Why? Because traditional payment processors, unfamiliar with the sector's subtleties, apply a generalized, indiscriminate "high-risk" policy. They see the word "CBD" and panic, ignoring the difference between a product that is perfectly legal in France (THC < 0.3%) and another in Italy (where THC is tolerated up to 0.6%).

This article is your compass. We will map out in detail the CBD regulations in key European markets: France, Germany, Spain, Italy, the Netherlands, and the United Kingdom. The goal: to give you the clarity needed to build your expansion strategy and, most importantly, to understand how to secure your cross-border revenue streams. Because in this industry, knowledge of the law is the first step towards a healthy and sustainable cash flow.

The Pan-European Context: The Kanavape Ruling and "Novel Food"

Before diving into national specificities, it's crucial to understand two concepts that shape CBD policy across the continent. These elements dictate the high-level conversation and influence the laws of each member state.

The CJEU's "Kanavape" Ruling: The Turning Point

In November 2020, the Court of Justice of the European Union (CJEU) delivered a landmark decision in the "Kanavape" case. It ruled that CBD extracted from the entire Cannabis sativa plant, if it does not contain THC in psychoactive quantities, is not a narcotic.

More importantly, the Court affirmed that a EU member state cannot prohibit the marketing of CBD legally produced in another member state, under the principle of the free movement of goods. This ruling forced many countries, including France, to revise their restrictive legislation and provided a solid legal foundation for the hemp industry throughout the EU.

The European Commission's "Novel Food" Catalogue

Meanwhile, the issue of CBD for consumption is governed by the "Novel Food" regulation. According to the European Commission, hemp extracts and products containing CBD are considered novel foods because significant consumption could not be demonstrated before May 1997.

Consequently, any company wishing to sell CBD intended for ingestion (oils, capsules, edibles) must submit a market authorization application to the European Food Safety Authority (EFSA). This process is long, expensive, and complex, pushing many players into a grey area, marketing their oils as cosmetic or "wellness" products not intended for ingestion. This distinction is fundamental and has major repercussions on a product's marketing and legality.

🇫🇷 France: From Reluctance to Controlled Openness

Authorized THC Level

The authorized tetrahydrocannabinol (THC) level in the hemp plant and finished products is 0.3%. This threshold is aligned with the European average and is the red line that must never be crossed for any product marketed in France.

Legal Status and Commercialization

France has one of the most tumultuous histories with CBD. Following the Kanavape ruling, the legislation was clarified. Today, the sale of CBD-based products is authorized for adults. This includes oils, cosmetics, e-liquids, and even raw flower and leaves, which were long prohibited. The sale of the latter is now permitted, provided they come from authorized varieties of Cannabis Sativa L. and their THC content is below 0.3%. However, it is strictly forbidden to make therapeutic claims or to promote consumption through smoking.

The Impact on Payments

France represents a mature but monitored market. Mainstream payment processors are often skittish, remembering the past legal instability. A French seller running a marketing campaign on "CBD flowers" could have their account suspended by a player like Stripe or PayPal, which would interpret this as a violation of their policies.

For cross-border sales, the complexity increases. A specialist CBD payment gateway like Bridge Pay is essential. We understand the legality of products compliant with the 0.3% THC standard and ensure that your transactions, whether domestic or to Germany, are not unduly blocked.

🇩🇪 Germany: The Economic Engine of European CBD

Authorized THC Level

In Germany, the legal limit for THC in products derived from industrial hemp is 0.2%. This threshold is slightly stricter than the French standard and must be rigorously respected.

Legal Status and Commercialization

Germany is the largest CBD market in Europe. The situation is relatively liberal, but not without its subtleties. CBD products that are not pure isolates generally fall under the "Novel Food" regulation. This means that to legally sell a full-spectrum CBD oil, an authorization is theoretically required.

In practice, the market is flooded with products that bypass this rule, often by labeling them as "aromatic products" not intended for consumption. CBD flowers are in an even more pronounced grey area; their sale to end consumers is often considered illegal by authorities if intended for inhalation, and many physical stores have been raided. Online commerce, however, remains very active.

The Impact on Payments

The German paradox is clear: a huge market with an underlying regulatory risk. This is a nightmare for traditional payment providers. They see the potential sales volume but are terrified by the risk of "grey areas," especially concerning flowers and unauthorized "Novel Food" products. Capturing the German market from France or Italy requires a gateway that doesn't take a binary approach. Bridge Pay assesses risk based on the compliance of your products in the country of sale AND origin, enabling smooth transactions where others see a dead end.

🇪🇸 Spain: A Complex and Regionalized Legal Framework

Authorized THC Level

Like Germany, Spain adheres to the 0.2% THC limit for hemp-based products.

Legal Status and Commercialization

Spain presents a textbook case of complexity. At the national level, the food safety agency (AECOSAN) has ruled that CBD cannot be sold as a food supplement. Consequently, the vast majority of CBD products (oils, flowers) are marketed under the label "for external use only" or as a "technical product" or "collector's item." This legal workaround allows online and physical stores to operate, but in a state of constant precariousness.

The situation is further complicated by regional regulations and the existence of social cannabis clubs, which operate under a separate legal framework not applicable to retail.

The Impact on Payments

For a payment processor, Spain is a red flag. The "external use" labeling is an obvious workaround that automated risk management systems can interpret as an attempt at deception. Many Spanish CBD merchants or those selling to Spain have experienced sudden account freezes.

Accepting payments for "collector's flowers" sold from Spain to a customer in France is a risk scenario that only a specialized gateway can handle. It must understand that despite the wording, the product is legally produced below the 0.2% THC threshold and that this practice is the market norm.

🇮🇹 Italy: The Land of "Cannabis Light"

Authorized THC Level

Italy is unique in Europe with a two-tiered approach to THC. The law allows the cultivation of hemp with a THC level up to 0.2%, but it introduces a tolerance for the final product, which can go up to 0.6%. This margin has given rise to the flourishing "Cannabis Light" market.

Legal Status and Commercialization

The Italian market has experienced a legal rollercoaster. After a period of explosive growth for "Cannabis Light" shops, the government attempted a crackdown before the Court of Cassation clarified that the sale of hemp and its derivatives without narcotic effects (which includes low-THC flowers) is not a crime. However, the products cannot be sold as "for smoking," and therapeutic claims are prohibited. The situation remains politically sensitive, but the market continues to thrive.

The Impact on Payments

The 0.6% THC threshold, even if tolerated, is anathema to international payment processors operating with strict rules based on 0.2% or 0.3%. Attempting to process a transaction for an Italian product labeled at 0.5% THC through a standard American gateway is a recipe for disaster. This is where the expertise of a European player like Bridge Pay becomes crucial. We know the specifics of the Italian Law 242/2016 and can configure risk rules to accept these legitimate transactions, ensuring the continuity of your sales in this lucrative but unique market.

🇬🇧 United Kingdom: The Post-Brexit Era and the "Novel Food" Rule

Authorized THC Level

The UK has one of the strictest policies: technically, THC is a controlled substance and the legal limit for a CBD product is 0%. In practice, a limit of 1mg of THC per container is applied as a de facto threshold, which is extremely low.

Legal Status and Commercialization

Since Brexit, the UK is no longer part of the European single market. The CBD industry there is now firmly governed by the Food Standards Agency (FSA) and its "Novel Food" regulation. Only products that are on the public list of validated applications by the FSA can remain on the market.

This measure has caused a massive consolidation of the sector, as many small brands could not afford to submit the expensive toxicological dossiers required. For European companies wishing to sell in the UK, this means they must either go through a British importer whose products are FSA-compliant or get their own products validated: a difficult process.

The Impact on Payments

Selling in the UK market is a challenge. Post-Brexit cross-border payments have already added friction. The "Novel Food" regulation adds another layer. A payment gateway must not only handle currencies (EUR/GBP) but also understand the associated risk. A merchant who cannot prove their products are on the FSA list will see their payments declined. Bridge Pay supports its clients by requiring the necessary documentation (such as Certificates of Analysis and proof of FSA submission) to build a solid case, thereby legitimizing the opening of stable payment corridors to the UK.

Comparative Table of CBD Regulations in Europe

FAQ: Frequently Asked Questions about CBD Payments in Europe

1. Why is CBD considered a "high-risk" sector by payment processors?

The CBD sector is classified as "high-risk" due to several factors: the heterogeneity of laws between countries, the historical association with recreational cannabis which creates regulatory uncertainty, potentially higher chargeback rates (payment disputes), and the very conservative internal policies of major card networks (Visa, Mastercard) and platforms like PayPal or Stripe.

2. Can I use a single payment provider to sell throughout Europe?

That's the goal, but it's difficult to achieve with a standard provider. A solution like Bridge Pay is designed for this. We create custom payment "corridors" by analyzing the legality of your products in your country and the destination country. This allows for a unified solution that adapts to different regulations, whereas a traditional player would apply a single restrictive policy for everyone.

3. Does the "Novel Food" requirement impact my payments?

Yes, indirectly but significantly. If you sell oils or capsules for ingestion without having a Novel Food authorization (or proof of application), a payment processor may consider that you are selling a non-compliant product and close your account to reduce its own legal risk. This is particularly true for the UK market.

4. Is it safer to only sell THC-free (isolate) products?

From a purely "payment" perspective, selling 0% THC products simplifies things slightly, as it removes any ambiguity about respecting legal thresholds. However, many consumers prefer broad-spectrum or full-spectrum products. The real issue is not avoiding THC, but proving that you respect the legal threshold of the country of sale. A competent payment partner should be able to handle <0.3% products just as well as isolates.

5. In practical terms, what documents does Bridge Pay require to open an account?

To ensure a healthy and lasting partnership, we require a complete file: your company's registration documents, directors' IDs, and most importantly, for your products: third-party lab Certificates of Analysis for each product category, technical data sheets, and if applicable, proof of submission to the Novel Food catalogue. This transparency allows us to defend your case to our partner banks and guarantee you a stable service.

Turn Complexity into Opportunity

The European CBD map is a complex patchwork, but each regulatory variation hides an opportunity for the savvy entrepreneur. Knowing the subtleties between Italy's 0.6% tolerance, Germany's strict 0.2%, and France's pragmatic 0.3% is not an academic exercise; it is the key to unlocking markets of millions of consumers. However, this knowledge is useless if you can't complete the final step: accepting your customer's payment.

Your choice of payment partner is as strategic as your choice of hemp supplier. Relying on a generalist solution is like building your empire on foundations of sand, at the mercy of an algorithm change or a misinterpretation of the law. Working with a high-risk specialist like Bridge Pay means choosing security, expertise, and predictability. We understand the nuances of your industry and translate regulatory complexity into risk management rules that protect and support your growth.

Don't let payment fragmentation slow your European expansion. Secure your revenue, protect your business, and focus on what you do best: offering quality products to your customers.

Ready to build a solid bridge for your CBD payments in Europe? Open your Bridge Pay account today.